DOI: https://dx.doi.org/10.18565/pharmateca.2022.14.34-40
Переверзина Н.О., Круглова Л.С., Коротаева Т.В., Лила А.М.
1) Центральная государственная медицинская академия УДП РФ, Москва, Россия; 2) Научно-исследовательский институт ревматологии им. В.А. Насоновой, Москва, Россия
1. Boehncke W.H., Sch n M.P. Psoriasis. Lancet. 2015;386(9997):983–94. Doi: 10.1016/ S0140-6736(14)61909-7. 2. Chimenti M.S., Caso F., Alivernini S., et al. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease. Autoimmun Rev. 2019;18(6):565–75. Doi: 10.1016/j.autrev.2018.11.007. 3. Veale D.J., Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391(10136):2273–84. Doi: 10.1016/S0140-6736(18)30830-4. 4. Кубанов А.А., Богданова Е.В. Организация и результаты оказания медицинской помощи по профилю «дерматовенерология» в Российской Федерации. Итоги 2018 г. Вестник дерматологии и венерологии. 2019.95(4):8–13. 5. Alinaghi F., Calov M., Kristensen L.E., et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019;80(1):251–65.e19. Doi: 10.1016/j.jaad.2018.06.027. 6. Коротаева Т.В., Корсакова Ю.Л., Логинова Е.Ю. и др. Псориатический артрит. Клинические рекомендации по диагностике и лечению. Современная ревматология. 2018;12(2):22–35. 7. Tillett W., Charlton R., Nightingale A., et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatol. (Oxford). 2017;56(12):2109–13. Doi: 10.1093/rheumatology/kex323. 8. Haroon M., Gallagher P., FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045–50. Doi: 10.1136/annrheumdis-2013-204858. 9. Burgers L.E., Raza K., van der Helm-van Mil A.H. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives. RMD Open. 2019;5(1):e000870. Doi: 0.1136/ rmdopen-2018-000870. 10. van Steenbergen H.W., da Silva J.A.P., Huizinga T.W.J., et al. Preventing progression from arthralgia to arthritis: targeting the right patients. Nat Rev Rheumatol. 2018;14(1):32–41. Doi: 10.1038/ nrrheum.2017.185. 11. McGonagle D., Tan A.L., Benjamin M. The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know. Ann Rheum Dis. 2008;67(1):1–4. Doi: 10.1136/ ard.2007.080952. 12. Tillett W., Jadon D., Shaddick G., et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis. 2013;72(8):1358–61. Doi: 10.1136/annrheumdis-2012-202608. 13. Lai T.L., Pang H.T., Cheuk Y.Y., et al. Psoriatic nail involvement and its relationship with distal interphalangeal joint disease. Clin Rheumatol. 2016;35(8):2031–37. Doi: 10.1007/s10067- 016-3319-5. 14. Taylor W., Gladman D., Helliwell P., et al. CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthr Rheum. 2006;54(8):2665–73. Doi: 10.1002/ art.21972. 15. Raposo I., Torres T. Nail psoriasis as a predictor of the development of psoriatic arthritis. Actas Dermosifiliogr. 2015;106(6):452–7. English, Spanish. Doi: 10.1016/j.ad.2015.02.005. 16. van Muijen M.E., van Hal T.W., Groenewoud H.M.M., et al. The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy. Psoriasis (Auckl). 2020;10:29–37. Doi: 10.2147/PTT.S270619. 17. Chaiyabutr C., Ungprasert P., Silpa-Archa N., et al. Psoriasis and Risk of Uveitis: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:9308341. Doi: 10.1155/2020/9308341. 18. El-Asrar A.M., Struyf S., Kangave D.., et al. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol. 2011;139(2):177–84. Doi: 10.1016/j.clim.2011.01.014. 19. Ooi K.G., Galatowicz G., Calder V.L., et al. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res. 2006;4(4):294– 309. Doi: 10.3121/cmr.4.4.294. 20. Queiro R., Morante I., Cabezas I. et al. HLA- B27 and psoriatic disease: a modern view of an old relationship. Rheumatol (Oxford). 2016;55(2):221–29. Doi: 10.1093/ rheumatology/kev296. 21. Wakefield D., Yates W., Amjadi S., et al. HLA- B27 Anterior Uveitis: Immunology and Immunopathology. Ocul Immunol Inflamm 2016;24(4):450–9. doi: 10.3109/09273948. 2016.1158283. 22. Gladman D.D. Axial disease in psoriatic arthritis. Curr Rheumatol Rep. 2007;9(6):455–60. Doi: 10.1007/s11926-007-0074-2. 23. Menter A, Korman NJ, et al.: American Academy of Dermatology Work Group, Guidelines of care for themanagementofpsoriasisandpsoriaticarthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137–74. Doi: 10.1016/j.jaad.2010.11.055. 24. Chandran V., Barrett J., Schentag C.T., et al. Axial psoriatic arthritis: updateonalongtermprospective study. J Rheumatol. 2009;36(12):2744–50. Doi: 10.3899/jrheum.090412. 25. Jadon D.R., Sengupta R., Nightingale A., et al. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017;76(4):701–7. Doi: 10.1136/ annrheumdis-2016-209853. 26. Ritchlin C.T., Colbert R.A., Gladman D.D. Psoriatic Arthritis. N Engl J Med. 2017 9;376(10):957– 970. doi: 10.1056/NEJMra1505557. Erratum in: N Engl J Med. 2017;376(21):2097. 27. Queiro R., Belzunegui J., Gonzalez C., et al. Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study. Clin Rheumatol. 2002;21(1):10–3. Doi: 10.1007/ s100670200003. 28. Haroon M., Winchester R., Giles J.T., et al. Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis. Clin Exp Rheumatol. 2017;35(2):270–6. 29. Chandran V., Tolusso D.C., Cook R.J., et al. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol. 2010;37(4):809–15. Doi: 10.3899/jrheum.091059. 30. Feld J., Chandran Varoon N., et al. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363–71. Doi: 10.1038/s41584- 018-0006-8. 31. Gladman D.D., Thavaneswaran A., Chandran V., et al. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011;70(12):2152– 54. Doi: 10.1136/ard.2011.150938. 32. Круглова Л.С., Львов А.Н., Пушкина А.В. Риски и предикторы развития псориатического артрита при псориазе и вопросы раннего назначения генно-инженерных биологических препаратов. Клиническая дерматология и венерология. 2020;19(3). 33. Stuart P.E., Nair R.P., Tsoi L.C., et al. Genome- wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. Am J Hum Genet. 2015;97(6):816–36. Doi: 10.1016/j. ajhg.2015.10.019. 34. Abji F., Pollock R.A., Liang K., et al. Brief Report: CXCL10 Is a Possible Biomarker for the Development of Psoriatic Arthritis Among Patients With Psoriasis. Arthr Rheumatol. 2016;68(12):2911–16. doi: 10.1002/ art.39800. 35. Pollock R.A., Abji F., Liang K., et al. Gene expression differences between psoriasis patients with and without inflammatory arthritis. J. Invest. Dermatol. 2015;135(2):620–23. Doi: 10.1038/ jid.2014.414. 36. Cretu D., Gao L., Liang K., et al. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers. Arthr Care Res. (Hoboken). 2018;70(3):454–61. Doi: 10.1002/acr.23298. 37. Frasca L., Palazzo R., Chimenti M.S., et al. Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. Front Immunol. 2018;9:1936. Doi: 10.3389/ fimmu.2018.01936. 38. Yuan Y., Qiu J., Lin Z.T., et al. Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthr Rheumatol. 2019;71(6):941–51. 39. Dolcino M., Lunardi C., Ottria A., et al. Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis. PLoS One. 2014;9(12):e115424. Doi: 10.1371/journal.pone.0115424. 40. Chimenti M.S., Triggianese P., Nuccetelli M., et al. Auto-reactions, autoimmunity and psoriatic arthritis. Autoimmun Rev. 2015;14(12):1142–6. doi: 10.1016/j.autrev.2015.08.003. 41. Fitzgerald O., Ritchlin C.T., Mease P.J. Biomarkers of radiographic progression in psoriatic arthritis: a report from the GRAPPA 2011 annual meeting. J Rheumatol. 2012;39(11):2189–92. Doi: 10.3899/jrheum.120820. 42. Mc Ardle A., Flatley B., Pennington S.R., et al. Early biomarkers of joint damage in rheumatoid and psoriatic arthritis. Arthr Res Ther. 2015;17(1):141. Doi: 10.1186/s13075-015- 0652-z. 43. Cretu D., Prassas I., Saraon P., et al. Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteom. 2014;11(1):27. Doi: 10.1186/1559- 0275-11-27. 44. Cretu D., Liang K., Saraon P., et al. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteom. 2015;12(1):1. Doi: 10.1186/1559- 0275-12-1. 45. Bronckers I.M.G.J., Bruins F.M., van Geel M.J., et al. Nail Involvement as a Predictor of Disease Severity in Paediatric Psoriasis: Follow-up Data from the Dutch ChildCAPTURE Registry. Acta Derm Venereol. 2019;99(2):152–57. Doi: 10.2340/00015555-3036. 46. Choi J.W., Kim B.R., Seo E., et al. Could Psoriatic Arthritis Be Easily Diagnosed from Current Suspicious Physical Findings in the Dermatology Clinic? Ann Dermatol. 2017;29(1):48–54. Doi: 10.5021/ad.2017.29.1.48. 47. Diani M., Perego S., Sansoni V., et al. Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients. Int JMol Sci. 2019;20(22):5617. Doi: 10.3390/ijms20225617. 48. Eder L., Law T., Chandran V., et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthr Care Res. (Hoboken). 2011;63(8):1091–97. Doi: 10.1002/acr.20496. 49. Ficco H.M., Citera G., Cocco J.A. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol. 2014;33(10):1489–93. Doi: 10.1007/s10067- 014-2651-x. 50. Gladman D.D., Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatol. (Oxford). 2011;50(1):25–31. Doi: 10.1093/ rheumatology/keq262. 51. Lai T.L., Pang H.T., Cheuk Y.Y., et al. Psoriatic nail involvement and its relationship with distal interphalangeal joint disease. Clin Rheumatol. 2016;35(8):2031–7. doi: 10.1007/s10067- 016-3319-5. 52. Love T.J., Gudjonsson J.E., Valdimarsson H., et al. Psoriatic arthritis and onycholysis - results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol. 2012;39(7):1441–44. Doi: 10.3899/jrheum.111298. 53. Langenbruch A., Radtke M.A., Krensel M., et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol. 2014;171(5):1123–28. Doi: 10.1111/bjd.13272. 54. Maejima H., Taniguchi T., Watarai A., et al. Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index. Int J Dermatol. 2010;49(8):901–6. Doi: 10.1111/j.1365-4632.2009.04452.x. 55. Yan D., Ahn R., Leslie S., et al. Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis. Dermatol Ther (Heidelb). 2018;8(4):593–604. Doi: 10.1007/ s13555-018-0266-x. 56. Yang Q., Qu L., Tian H., et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25(12):1409–14. Doi: 10.1111/j.1468-3083.2011.03985.x. 57. Zargari O., Leyli E.K., Azimi S.Z. Nail Involvement in Patients with Psoriatic Arthritis in Northern Iran. Autoimmun. Dis. 2018;2018:4608490. Doi: 10.1155/2018/4608490. 58. Zenke Y., Ohara Y., Kobayashi D., et al. Nail findings in patients with psoriatic arthritis: A cross-sectional study with special reference to transverse grooves. J Am Acad Dermatol. 2017;77(5):863– 67. Doi: 10.1016/j.jaad.2017.04.001.
Автор для связи: Наталья Олеговна Переверзина, Центральная государственная медицинская академия УДП РФ, Москва, Россия; natalia.pereverzina@gmail.com ORCID:
Н.О. Переверзина (N.O. Pereverzina), https://orcid.org/0000-0003-1563-9475
Л.С. Круглова (L.S. Kruglova), https://orcid.org/0000-0002-5044-5265
Т.В. Коротаева (T.V. Korotaeva), https://orcid.org/0000-0003-0579-1131
А.М. Лила (A.M. Lila), https://orcid.org/0000-0002-6068-3080